183 related articles for article (PubMed ID: 30617948)
1. Use of a Novel Probiotic Formulation to Alleviate Lactose Intolerance Symptoms-a Pilot Study.
Gingold-Belfer R; Levy S; Layfer O; Pakanaev L; Niv Y; Dickman R; Perets TT
Probiotics Antimicrob Proteins; 2020 Mar; 12(1):112-118. PubMed ID: 30617948
[TBL] [Abstract][Full Text] [Related]
2. Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects.
Sanders SW; Tolman KG; Reitberg DP
Clin Pharm; 1992 Jun; 11(6):533-8. PubMed ID: 1534729
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of i3.1 Probiotic on Improvement of Lactose Intolerance Symptoms: A Randomized, Placebo-controlled Clinical Trial.
Cano-Contreras AD; Minero Alfaro IJ; Medina López VM; Amieva Balmori M; Remes Troche JM; Espadaler Mazo J; Perez Lopez N
J Clin Gastroenterol; 2022 Feb; 56(2):141-147. PubMed ID: 33136781
[TBL] [Abstract][Full Text] [Related]
4. beta-Galactosidase from Aspergillus niger in adult lactose malabsorption: a double-blind crossover study.
Corazza GR; Benati G; Sorge M; Strocchi A; Calza G; Gasbarrini G
Aliment Pharmacol Ther; 1992 Feb; 6(1):61-6. PubMed ID: 1543816
[TBL] [Abstract][Full Text] [Related]
5. Beta-galactosidase tablets in the treatment of lactose intolerance in pediatrics.
Medow MS; Thek KD; Newman LJ; Berezin S; Glassman MS; Schwarz SM
Am J Dis Child; 1990 Nov; 144(11):1261-4. PubMed ID: 2122719
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients.
Almeida CC; Lorena SL; Pavan CR; Akasaka HM; Mesquita MA
Nutr Clin Pract; 2012 Apr; 27(2):247-51. PubMed ID: 22402407
[TBL] [Abstract][Full Text] [Related]
7. Effects of Prebiotic and Probiotic Supplementation on Lactase Deficiency and Lactose Intolerance: A Systematic Review of Controlled Trials.
Leis R; de Castro MJ; de Lamas C; Picáns R; Couce ML
Nutrients; 2020 May; 12(5):. PubMed ID: 32443748
[TBL] [Abstract][Full Text] [Related]
8. The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial.
Pakdaman MN; Udani JK; Molina JP; Shahani M
Nutr J; 2016 May; 15(1):56. PubMed ID: 27207411
[TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement for lactose malabsorption using a beta-D-galactosidase.
DiPalma JA; Collins MS
J Clin Gastroenterol; 1989 Jun; 11(3):290-3. PubMed ID: 2502573
[TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous lactase administration on hydrogen breath excretion and intestinal symptoms in patients presenting lactose malabsorption and intolerance.
Ibba I; Gilli A; Boi MF; Usai P
Biomed Res Int; 2014; 2014():680196. PubMed ID: 24967391
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial.
Ojetti V; Gigante G; Gabrielli M; Ainora ME; Mannocci A; Lauritano EC; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):163-70. PubMed ID: 20391953
[TBL] [Abstract][Full Text] [Related]
12. [Effect of exogenous lactase on the absorption of lactose and its intolerance symptoms].
He M; Yang Y; Bian L; Cui H
Wei Sheng Yan Jiu; 1999 Sep; 28(5):309-11. PubMed ID: 12712706
[TBL] [Abstract][Full Text] [Related]
13. Respiratory methane excretion in children with lactose intolerance.
Medow MS; Glassman MS; Schwarz SM; Newman LJ
Dig Dis Sci; 1993 Feb; 38(2):328-32. PubMed ID: 8425445
[TBL] [Abstract][Full Text] [Related]
14. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment.
Fernández-Bañares F; Rosinach M; Esteve M; Forné M; Espinós JC; Maria Viver J
Clin Nutr; 2006 Oct; 25(5):824-31. PubMed ID: 16410032
[TBL] [Abstract][Full Text] [Related]
15. Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study.
Montalto M; Nucera G; Santoro L; Curigliano V; Vastola M; Covino M; Cuoco L; Manna R; Gasbarrini A; Gasbarrini G
Eur J Clin Nutr; 2005 Apr; 59(4):489-93. PubMed ID: 15674309
[TBL] [Abstract][Full Text] [Related]
16. Lactose intolerance and intestinal villi morphology in Thai people.
Thong-Ngam D; Suwangool P; Prempracha J; Tangkijvanich P; Vivatvekin B; Sriratanabun A
J Med Assoc Thai; 2001 Aug; 84(8):1090-6. PubMed ID: 11758841
[TBL] [Abstract][Full Text] [Related]
17. Effects of
Vitellio P; Celano G; Bonfrate L; Gobbetti M; Portincasa P; De Angelis M
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31010241
[TBL] [Abstract][Full Text] [Related]
18. Lactose malabsorption diagnosed by 50-g dose is inferior to assess clinical intolerance and to predict response to milk withdrawal than 25-g dose in an endemic area.
Ghoshal UC; Kumar S; Misra A; Mittal B
J Gastroenterol Hepatol; 2013 Sep; 28(9):1462-8. PubMed ID: 23701423
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement therapy for primary adult lactase deficiency. Effective reduction of lactose malabsorption and milk intolerance by direct addition of beta-galactosidase to milk at mealtime.
Rosado JL; Solomons NW; Lisker R; Bourges H
Gastroenterology; 1984 Nov; 87(5):1072-82. PubMed ID: 6434367
[TBL] [Abstract][Full Text] [Related]
20. Development, validation, and applicability of a symptoms questionnaire for lactose malabsorption screening.
Casellas F; Varela E; Aparici A; Casaus M; Rodríguez P
Dig Dis Sci; 2009 May; 54(5):1059-65. PubMed ID: 18716868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]